Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
You can purchase shares of Immunovant (NASDAQ:IMVT) through any online brokerage.
Other companies in Immunovant’s space includes: Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and TG Therapeutics (NASDAQ:TGTX).
Immunovant has a consensus price target of $40.53.
The stock price for Immunovant (NASDAQ: IMVT) is $28.61 last updated September 25, 2024 at 11:14 AM EDT.
There are no upcoming dividends for Immunovant.
Immunovant’s Q2 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Immunovant.
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.